Czechia, July 23 -- Czechia based PROMEDICA PRAHA GROUP, a.s. has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents - Drug supplies - RITUXIMAB 2026 . The value of the contract is worth 33776000 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....